Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus
- 3 March 2022
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 234, 114204
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Discovery of Wall Teichoic Acid Inhibitors as Potential Anti-MRSA β-Lactam Combination AgentsChemistry & Biology, 2013
- MRSA prevalence in european healthcare settings: a reviewBMC Infectious Diseases, 2011
- High Rates ofStaphylococcus aureusUSA400 Infection, Northern CanadaEmerging Infectious Diseases, 2011
- Role of Surface Protein SasG in Biofilm Formation by Staphylococcus aureusJournal of Bacteriology, 2010
- Origins and Evolution of Antibiotic ResistanceMicrobiology and Molecular Biology Reviews, 2010
- Roles of 34 Virulence Genes in the Evolution of Hospital‐ and Community‐Associated Strains of Methicillin‐ResistantStaphylococcus aureusThe Journal of Infectious Diseases, 2006
- Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream InfectionsClinical Infectious Diseases, 2006
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- The post-antibiotic sub-MIC effect in vitro and in vivoJournal of Antimicrobial Chemotherapy, 1993
- [30] Assay of hemolytic toxins1988